Dr. Jeffrey Shije, MD

NPI: 1972894095
Total Payments
$14,204
2024 Payments
$105.82
Companies
20
Transactions
49
Medicare Patients
1,218
Medicare Billing
$78,081

Payment Breakdown by Category

Consulting$6,545 (46.1%)
Other$6,039 (42.5%)
Food & Beverage$1,549 (10.9%)
Education$70.24 (0.5%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $6,545 2 46.1%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,039 4 42.5%
Food and Beverage $1,549 41 10.9%
Education $70.24 2 0.5%

Top Paying Companies

Company Total Records Latest Year
Alnylam Pharmaceuticals Inc. $6,713 4 $0 (2021)
CSL Behring $6,068 4 $0 (2020)
Alexion Pharmaceuticals, Inc. $364.18 4 $0 (2024)
UCB, Inc. $219.91 4 $0 (2024)
Akcea Therapeutics, Inc. $217.22 2 $0 (2019)
Genentech, Inc. $145.02 1 $0 (2022)
Lundbeck LLC $99.39 5 $0 (2019)
Sunovion Pharmaceuticals Inc. $60.84 4 $0 (2017)
Mallinckrodt LLC $54.40 4 $0 (2017)
Acorda Therapeutics, Inc $37.77 3 $0 (2019)

Payment History by Year

Year Amount Transactions Top Company
2024 $105.82 2 UCB, Inc. ($75.55)
2023 $247.07 3 Alexion Pharmaceuticals, Inc. ($131.88)
2022 $145.02 1 Genentech, Inc. ($145.02)
2021 $4,429 3 Alnylam Pharmaceuticals Inc. ($4,346)
2020 $8,382 4 CSL Behring ($6,002)
2019 $320.99 7 Akcea Therapeutics, Inc. ($217.22)
2018 $287.09 10 Alexion Pharmaceuticals, Inc. ($118.42)
2017 $286.97 19 Sunovion Pharmaceuticals Inc. ($60.84)

All Payment Transactions

49 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
02/05/2024 UCB, Inc. Rystiggo (Drug) Food and Beverage In-kind items and services $75.55 General
Category: Neurology
01/31/2024 Alexion Pharmaceuticals, Inc. ULTOMIRIS (Biological) Food and Beverage In-kind items and services $30.27 General
Category: Rare Disease
12/07/2023 UCB, Inc. Food and Beverage In-kind items and services $98.27 General
11/08/2023 Biogen, Inc. SPINRAZA (Biological), QALSODY Food and Beverage In-kind items and services $16.92 General
Category: Neurology
11/01/2023 Alexion Pharmaceuticals, Inc. SOLIRIS (Biological) Food and Beverage In-kind items and services $131.88 General
Category: Rare Disease
09/22/2022 Genentech, Inc. Evrysdi (Drug) Food and Beverage In-kind items and services $145.02 General
Category: Neurology
10/13/2021 Alexion Pharmaceuticals, Inc. Soliris (Drug) Food and Beverage In-kind items and services $83.61 General
Category: Immunology
06/03/2021 Alnylam Pharmaceuticals Inc. ONPATTRO (Drug) Consulting Fee Cash or cash equivalent $4,235.00 General
Category: Genetic Disease
05/05/2021 Alnylam Pharmaceuticals Inc. ONPATTRO (Drug) Food and Beverage In-kind items and services $110.50 General
Category: Genetic Disease
12/24/2020 CSL Behring Privigen (Biological), Hizentra Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $6,001.67 General
Category: Immunology
12/17/2020 Alnylam Pharmaceuticals Inc. ONPATTRO (Drug) Consulting Fee Cash or cash equivalent $2,310.00 General
Category: Genetic Disease
11/16/2020 Alnylam Pharmaceuticals Inc. Education In-kind items and services $57.50 General
02/05/2020 Mitsubishi Tanabe Pharma America, Inc. Education In-kind items and services $12.74 General
06/13/2019 CSL Behring Hizentra (Biological) Food and Beverage Cash or cash equivalent $23.93 General
Category: Immunology
06/05/2019 Akcea Therapeutics, Inc. TEGSEDI (Drug) Food and Beverage In-kind items and services $104.72 General
Category: NEUROLOGY
05/02/2019 Akcea Therapeutics, Inc. TEGSEDI (Drug) Food and Beverage In-kind items and services $112.50 General
Category: NEUROLOGY
04/16/2019 Avanir Pharmaceuticals, Inc. NUEDEXTA (Drug) Food and Beverage In-kind items and services $23.48 General
Category: pseudobulbar affect (PBA)
04/02/2019 Acorda Therapeutics, Inc INBRIJA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $13.77 General
Category: PARKINSONS DISEASE
03/28/2019 CSL Behring Hizentra (Biological) Food and Beverage Cash or cash equivalent $23.21 General
Category: Immunology
01/17/2019 Lundbeck LLC NORTHERA (Drug) Food and Beverage Cash or cash equivalent $19.38 General
Category: NEUROLOGY
11/30/2018 CSL Behring Hizentra (Biological) Food and Beverage In-kind items and services $19.46 General
Category: Immunology
11/16/2018 Lundbeck LLC NORTHERA (Drug) Food and Beverage Cash or cash equivalent $17.60 General
Category: NEUROLOGY
10/25/2018 Acorda Therapeutics, Inc AMPYRA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $11.96 General
Category: MULTIPLE SCLEROSIS
09/27/2018 Acorda Therapeutics, Inc AMPYRA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $12.04 General
Category: MULTIPLE SCLEROSIS
08/31/2018 Lundbeck LLC NORTHERA (Drug) Food and Beverage Cash or cash equivalent $20.18 General
Category: NEUROLOGY

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 9 341 391 $98,624 $18,853
2022 9 319 377 $97,218 $18,275
2021 7 195 235 $58,005 $12,083
2020 11 363 462 $130,497 $28,870
Total Patients
1,218
Total Services
1,465
Medicare Billing
$78,081
Procedure Codes
42

All Medicare Procedures & Services

42 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2023 48 48 $21,244 $4,509 21.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 50 56 $18,192 $3,753 20.6%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Facility 2023 70 92 $17,285 $2,944 17.0%
95908 Nerve conduction, 3-4 studies Facility 2023 45 45 $10,917 $2,116 19.4%
95909 Nerve conduction, 5-6 studies Facility 2023 30 30 $8,340 $1,630 19.5%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 11 17 $3,528 $1,040 29.5%
95910 Nerve conduction, 7-8 studies Facility 2023 16 16 $6,289 $1,006 16.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 18 19 $4,475 $972.04 21.7%
95885 Needle measurement of electrical activity in arm or leg muscles, limited study Facility 2023 53 68 $8,354 $883.52 10.6%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 28 28 $12,712 $2,998 23.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 30 37 $11,104 $2,712 24.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 26 43 $8,648 $2,411 27.9%
95886 Needle measurement of electrical activity in arm or leg muscles, complete study Facility 2022 62 75 $16,050 $2,263 14.1%
95910 Nerve conduction, 7-8 studies Facility 2022 34 34 $14,008 $2,016 14.4%
99222 Initial hospital inpatient care per day, typically 50 minutes Facility 2022 19 19 $7,353 $2,001 27.2%
95909 Nerve conduction, 5-6 studies Facility 2022 25 25 $7,700 $1,441 18.7%
95908 Nerve conduction, 3-4 studies Facility 2022 31 31 $7,998 $1,312 16.4%
95885 Needle measurement of electrical activity in arm or leg muscles, limited study Facility 2022 64 85 $11,645 $1,121 9.6%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 18 24 $6,182 $1,827 29.6%
95911 Nerve transmission studies, 9-10 studies Facility 2021 18 18 $11,082 $1,785 16.1%
95886 Needle measurement and recording of electrical activity of muscles of arm or leg complete study Facility 2021 32 42 $7,539 $1,550 20.6%
95911 Nerve transmission studies, 9-10 studies Office 2021 14 14 $9,030 $1,495 16.6%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 29 31 $5,280 $1,476 28.0%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 12 12 $4,956 $1,324 26.7%
95910 Nerve transmission studies, 7-8 studies Facility 2021 12 12 $5,356 $969.68 18.1%

About Dr. Jeffrey Shije, MD

Dr. Jeffrey Shije, MD is a Neurology healthcare provider based in Phoenix, Arizona. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2011. The National Provider Identifier (NPI) number assigned to this provider is 1972894095.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Shije, MD has received a total of $14,204 in payments from pharmaceutical and medical device companies, with $105.82 received in 2024. These payments were reported across 49 transactions from 20 companies. The most common payment nature is "Consulting Fee" ($6,545).

As a Medicare-enrolled provider, Shije has provided services to 1,218 Medicare beneficiaries, totaling 1,465 services with total Medicare billing of $78,081. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.

Practice Information

  • Specialty Neurology
  • Other Specialties Neurology, Neurology
  • Location Phoenix, AZ
  • Active Since 04/23/2011
  • Last Updated 07/05/2025
  • Taxonomy Code 2084N0400X
  • Entity Type Individual
  • NPI Number 1972894095

Products in Payments

  • ONPATTRO (Drug) $6,656
  • Privigen (Biological) $6,002
  • TEGSEDI (Drug) $217.22
  • Evrysdi (Drug) $145.02
  • SOLIRIS (Biological) $131.88
  • SOLIRIS (Drug) $118.42
  • NORTHERA (Drug) $99.39
  • Soliris (Drug) $83.61
  • Rystiggo (Drug) $75.55
  • Hizentra (Biological) $66.60
  • APTIOM (Drug) $60.84
  • ACTHAR (Biological) $54.40
  • Neupro (Drug) $46.09
  • OXTELLAR XR (Drug) $31.17
  • ULTOMIRIS (Biological) $30.27
  • COPAXONE (Drug) $30.09
  • AMPYRA (Drug) $24.00
  • GILENYA (Drug) $23.64
  • NUEDEXTA (Drug) $23.48
  • SPINRAZA (Biological) $16.92

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Neurology Doctors in Phoenix